We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NovaDel Announces Termination of Oral Spray License Agreements

News   Jan 23, 2012

 
NovaDel Announces Termination of Oral Spray License Agreements
 
 
 

RELATED ARTICLES

Human Gene Linked to a Better Recovery From Stroke

News

Neuroscientists have found that patients born without a gene called CCR5 recover better from mild stroke than patients with the gene.

READ MORE

Novel Therapeutic Approach to Treat Osteoarthritis

News

Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.

READ MORE

Machine Learning Swiftly Analyzes Nanomedicines for Cancer Immunotherapy

News

With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE